Cummings Keith Lamont

Track

Insider profile

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cummings Keith Lamont's trades of Pliant Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-22 2026-01-20
PlS Planned sale
22,797 -43.1%
174.38
US$3,721,495 		22,797 -43.1% 174.38 US$3,721,495
2025-01-22 2025-01-17
PlS Planned sale
53,094 +29.3%
214.21
US$3,832,968 		53,094 +29.3% 214.21 US$3,832,968
2024-07-12 2024-07-10
PlS Planned sale
13,334 -4.9%
440.11
US$3,096,459 		13,334 -4.9% 440.11 US$3,096,459
2024-01-19 2024-01-17
PlS Planned sale
9,781 -4.8%
17.23
US$168,527 		9,781 -4.8% 17.23 US$168,527
2023-07-19 2023-07-17
PlS Planned sale
19,771 -8.8%
18.01
US$356,058 		19,771 -8.8% 18.01 US$356,058
2023-04-03 2023-03-30
PlS Planned sale
9,960 -6.3%
26.52
US$264,148 		9,960 -6.3% 26.52 US$264,148
2023-01-25 2023-01-23
PlS Planned sale
30,000 -26.2%
35.00
US$1,050,000 		30,000 -26.2% 35.00 US$1,050,000
2022-12-21 2022-12-20
S Sale
9,643 -10.7%
19.10
US$184,204 		9,643 -10.7% 19.10 US$184,204
2020-12-02 2020-12-01
PlS Planned sale
846 -3.5%
30.72
US$25,989 		846 -3.5% 30.72 US$25,989
2020-12-02 2020-12-01
PlS Planned sale
14,901 -99.8%
30.21
US$450,159 		14,901 -99.8% 30.21 US$450,159
2020-12-02 2020-12-01
PlS Planned sale
1,848 -4.5%
29.07
US$53,721 		1,848 -4.5% 29.07 US$53,721
2020-12-02 2020-12-01
PlS Planned sale
1,139 -2.7%
28.24
US$32,165 		1,139 -2.7% 28.24 US$32,165